Presentation

MDRenal is a well-funded privately held biotechnology company specializing in the field of biometrics. Its work focuses on the development of mass-spectrometry based analytical tools for targeted metabolomics.

Metabolomics offers a wide range of applications, specially related to toxicology and pharmacological evaluation. It allows for rapid detection and quantification of changes in the levels of metabolites in pathology, and aids in tracking the metabolism of an administrated drug. It is also applied in the discovery of new biomarkers for non-invasive early diagnosis.

MDRenal produces tools for the rapid identification, quantification, and interpretation of metabolites in biofluids, pioneering innovative solutions for our clients. Our work is made possible thanks to a multidisciplinary team with specializations across diverse fields such as Biochemistry, Physical Chemistry, Analytical Chemistry and Bioinformatics.

MDRenal maintains close contacts with other leading research centers, hospitals, and biotechnological companies working actively in metabolomics. These institutions collaborate with MDRenal on projects ranging from product validation to Research & Development proposals.